KDR and glioma: Of note, BEV-induced invasiveness of VEGFR-2-positive glioma cells was concentration-dependent as treatment with low-dosed BEV (1 mg/ml) resulted in 1.6-fold increased invasion, whereas high-dosed BEV (3 mg/ml) stimulated invasion by more than 3-fold (Figure 4A).